Join Luma promotes $149-a-month compounded tirzepatide plan after Venture Magazine price comparison
HappyScale Wellness Corp., trading as Join Luma, says a seven-provider comparison ranked it cheapest for compounded tirzepatide, while noting the product is not FDA-approved.
HappyScale Wellness Corp., which trades as Join Luma, said on 11 November 2026 that it ranked first on price in a Venture Magazine comparison of seven compounded tirzepatide providers. The comparison was published on 6 November. The online weight-management platform issued the announcement itself; the Venture Magazine article was not available for review.
The company's featured offer is a six-month self-pay plan for people who already use GLP-1 medicines. It costs $149 per month, with the full $894 billed upfront.
The release carries a disclaimer that compounded tirzepatide is not FDA-approved. It also says the product has not been reviewed by the FDA for safety, effectiveness or quality, and that a lower price does not show equivalence to an approved drug.
As general context, compounded medicines are prepared by pharmacies outside the FDA's product approval process, so they are not assessed for safety and efficacy in the way authorised products are. The source gives no further detail on the comparison's methodology, the other six providers or the pricing they offered.
What it means for your team
- Price-led marketing of compounded GLP-1 products continues, and the company's own release stresses that they lack FDA approval and review.
- Pharmacovigilance and quality teams should note that compounded products sit outside standard approval and reporting routes, which may limit the safety data available.
- Market-access and brand teams can treat low self-pay prices from compounders as a competitive reference point, but the release makes no claim of equivalence to approved drugs.
Company's press release: HappyScale Wellness Corp. d/b/a Join Luma ↗
Article written by VigiEye from the official source (HappyScale Wellness Corp. d/b/a Join Luma). Claims are the company's own. AI-assisted; check the source before acting.